Network·Venture Capital
📍 Boston, Massachusetts
The T1D Fund is a venture impact fund focused on accelerating treatments, prevention, and cures for Type 1 Diabetes through equity investments in early-stage biotech companies developing disease-modifying therapies. Managing over $250 million in assets under management with 25+ portfolio companies, the fund reinvests 100% of returns to support its mission.
🔒 Sign up for free to view key contact information
Sign up free →This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
Check Size
$250M–$250M
Location
Boston, Massachusetts
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.